These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21094422)

  • 1. Replicon particle vaccine protects swine against influenza.
    Bosworth B; Erdman MM; Stine DL; Harris I; Irwin C; Jens M; Loynachan A; Kamrud K; Harris DL
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e99-e103. PubMed ID: 21094422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept.
    Erdman MM; Kamrud KI; Harris DL; Smith J
    Vaccine; 2010 Jan; 28(3):594-6. PubMed ID: 19853679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
    Vander Veen RL; Loynachan AT; Mogler MA; Russell BJ; Harris DL; Kamrud KI
    Vaccine; 2012 Mar; 30(11):1944-50. PubMed ID: 22269873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.
    Tian ZJ; Zhou GH; Zheng BL; Qiu HJ; Ni JQ; Yang HL; Yin XN; Hu SP; Tong GZ
    Vet Immunol Immunopathol; 2006 Jun; 111(3-4):211-8. PubMed ID: 16621018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
    Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
    Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).
    Sipo I; Knauf M; Fechner H; Poller W; Planz O; Kurth R; Norley S
    Vaccine; 2011 Feb; 29(8):1690-9. PubMed ID: 21195079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
    James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
    Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
    Kitikoon P; Vincent AL; Jones KR; Nilubol D; Yu S; Janke BH; Thacker BJ; Thacker EL
    Vet Microbiol; 2009 Nov; 139(3-4):235-44. PubMed ID: 19595522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
    Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
    Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.